The point of starting Oncotarget was so that Mikhail Blagosklonny would have a place where he could research different things. He tried hard to make sure that he was doing everything right and that he would be able to show people different opportunities for treatment. It was something that was a huge part of the review publication where peers could do research on different subjects. It was also something that Mikhail Blagosklonny was confident in and something that he tried hard to make better for all of the people who he was working with. Since Mikhail Blagosklonny started Oncotarget, he has been able to learn different things and has been able to make things better for all of the other peers that are a part of the publication with the different options that they have available to them and in the different areas that they are experts on cancer treatment.
The expert advice that Mikhail Blagosklonny has been giving to people is something that makes Oncotarget so valuable. Without it, doctors wouldn’t be able to connect with Oncotraget who are not in their special fields. They would worry about what they could be doing for their patients and they would probably be concerned about the issues that were going on in their fields. It was something that made it hard for people to realize and something that was different from anything else that other companies had offered in the past.
Mikhail Blagosklonny knew that Oncotarget could be successful for other people.Since Oncotarget has grown and more specialists have joined the publication, Mikhail Blagosklonny has seen a lot of changes. He has been able to keep track of the different things that Oncotarget does and that has helped him to make a difference in the world that he is in. Mikhail Blagosklonny is confident with the skills that he has and he has tried hard to make Oncotarget better. All of the people who work with Oncotarget also work to make sure that others are going to be able to benefit from it so that they can try different things in the practices that they have.
InnovaCare is a well-known quality health provider based in North America. It specializes in the provision of Medicaid and Medicare Advantage programs. The programs offer Americans Mexicans an affordable health plan that caters to most of the medical concerns. InnovaCare Health values the lives of all people and has an undeterred focus to install life changing plans in society. They rotate their works around patience and quality to maintain consistently good treatment without discriminating against varying socio economic statuses.
InnovaCare has a highly professional administrative team that works cooperatively and diligently to ascertain the smooth operations of Medicare and Medicaid programs. The president and chief executive officer Rick Shinto has an extensive leadership portfolio in the medical field that has fully equipped him with the will power and knowledge to raise InnovaCare’s performance to a world status.
Richard who is known by his alias name Rick received his bachelors from the University of California before specializing in medicine at the State University of New York. He then enrolled into the University of Redlands where he acquired a postgraduate degree in business administration. Richard’s first job was in Southern California where he interned as a pulmonologist. He has a working experience with Aveta Corporation as a chief executive officer for four years and NAMM as a chief medical officer and head operations manager. He served at MedPartners as a corporate vice president and left to work for Cal Optima Health, a position he held until he joined InnovaCare Health.
InnovaCare’s human resource team added three competitive professionals in June 2015 with the helpful input of Rick Shinto. The three included Penelope Kokkinides, a seasoned leader who has expertise in running the Medicaid and Medicare programs. Penelope’s resume entails working for Centerlight Healthcare as an executive vice president and chief operating officer. She worked for Touchstone Health as a chief operating officer and served as a vice president for Care Management and Disease. Penelope joined InnovaCare as a chief administrative officer and commented that the recruitment was an honorable experience in her career.
Penelope is an alumnus of Binghamton University who has a bachelors in biological sciences and classical languages. She has master’s degree in public health from New York University and social works from Colombia University. She has post masters degree in alcohol and substance abuse from New York University. Her rich educations and invaluable working experience give her an unmatched vision in creating the best health plans for Americans.
Comprehensive treatment for breast cancer has evaded health specialists for decades. What could be the reason for this situation? What has not been done in spite of billions of dollars used in research and treatment? Fortunately, Tempus, a cancer-fighting startup from Groupon founder Erick Lefkofsky has discovered the gap and come up with a solution.Tempus has observed that despite the rising number of deaths from breast cancer, its data collection, storage and use has remained minimal. Effective treatment of breast cancer calls for past records on how it starts, the interventions carried out and its prognosis.
Cancer is an abnormal growth and proliferation of cells. For effective treatment, it is important to study the molecular cell abnormalities and genetic mutation that make cancer cells unresponsive to chemotherapy. This study phase has been conducted by many research centers and hospitals. Unfortunately, the studies and research data have remained in individual research centers and hospitals.Tempus has come out to remedy this situation. The organization plans to break this individual approach in breast cancer treatment by introducing an operating system for cancer patients. Tempus, in partnership with the University of Chicago Medicine, will analyze the data in this platform from the over 1,000 breast cancer patients. The data collected and analyzed will assist doctors and researchers in uncovering the patterns that can predict how patients will respond to treatment.
Cancer treatment presents a challenge as it requires targeted therapy of the cancerous cells. Besides, the constant mutations and individual genetic makeup further complicate the treatment regimen. To overcome this hindrance, Tempus uses machines learning and genomic sequencing to help physicians in making real-time personalized treatment judgments.To help in realizing this patient focused treatment dubbed Precision Promise trial, Tempus has been selected by Pancreatic Cancer Action Network (PANCan) to utilize its technology in supporting this revolutionary effort.
Erick Lefkofsky is the co-founder and CEO of Tempus, the technological company that has built an operating system to battle cancer. He has a degree from the University of Michigan and a Juris Doctor from University of Michigan Law School. He is the author of Accelerated Disruption and is currently an adjunct professor at the University of Chicago.Lefkofsky is the co-founder of Lightbank and Uptake Technologies. Together with his wife, Liz, they have established Lefkofsky Family Foundation to assist disadvantaged communities.
Capitol Anesthesiology Association (CAA) is an independent practice for the physicians with specialties in anesthesiology. The Texas-based practice comprises of over 80 physicians and 130 Certified Registered Nurse Anesthetics (CRNAs). CAA has well-trained physicians (MDs) in various fields of anesthesia including obstetric, cardiothoracic, and pediatric anesthesiology. The physicians practicing at the association require the certification from the American Board of Anesthesiology during their period of work.
The operations at CAA
The MDs and the CRNAs at Capitol Anesthesiology Association provide a safe anesthesiology experience to over 20 medical facilities in greater Austin Area. The administrative staff at CAA works hand in hand with anesthesia personnel and insurance companies to run a smooth billing process. Capitol Anesthesiology Association focuses on providing anesthesia services for the pain alleviation before, during, and after surgery.
Types of Anesthesia
The different types of anesthesia available include the general anesthesia, regional anesthesia, and local/monitored anesthesia. The CRNAs administer general anesthesia in an extensive surgery that requires the patients to be unconscious. The regional/local anesthesia alleviates pain on a small part of the body, for example, an arm, leg, or lower part of the abdomen. The local anesthesia controls pain during the operations on the small areas of soft tissues. Other types of anesthesia used by CAA include pediatric, obstetric, cardiovascular, and thoracic anesthesia.
Capitol Anesthesiology Association is a great supporter of different non-profit based organizations in Austin. Groups that they have previously worked with in the past include Austin Smiles, Dell Children’s Surgical Global Outreach, Eels on Wheels, Operation Smile, Children’s Medical Center Foundation, Family Eldercare, and Partnerships for Children.